MDWD vs NAGE: stock comparison and AI forecast
Mediwound Ltd. (MDWD) and Niagen Bioscience, Inc. (NAGE) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
MDWD Mediwound Ltd.
- Price
- $13.33 -22.8% · 6M
- Market Cap
- $171M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
NAGE Niagen Bioscience, Inc.
- Market Cap
- $164M
- P/E Ratio
- 14.8x
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MDWD and NAGE have similar market capitalizations ($171M and $164M).
- NAGE turns 8.4% of its revenue into net income, against -153.8% for MDWD.
- MDWD carries 0.98 times debt per unit of equity, against 0.31 times for NAGE.
- Both companies share the SEC industry classification Medicinal Chemicals & Botanical Products.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | MDWD | NAGE |
|---|---|---|
| Market Cap | $171M | $164M |
| P/E Ratio | – | 14.78x |
| P/B Ratio | – | 1.97x |
| EPS | $-7.04 | $0.14 |
| Book Value/Share | – | $1.05 |
| Revenue/Share | $3.74 | $1.55 |
| FCF/Share | $-4.28 | – |
Profitability & Margins
| Metric | MDWD | NAGE |
|---|---|---|
| ROE | -169.0% | 12.3% |
| ROA | -85.5% | 9.4% |
| ROIC | -90.6% | 5.2% |
| Gross Margin | 16.0% | 63.9% |
| Operating Margin | -114.4% | 3.9% |
| Net Margin | -153.8% | 8.4% |
| EBT Margin | -153.2% | 9.0% |
| Tax Rate | -0.4% | 7.4% |
Financial Health
| Metric | MDWD | NAGE |
|---|---|---|
| Current Ratio | 2.33x | 5.93x |
| Quick Ratio | 2.17x | 4.71x |
| D/E Ratio | 0.98x | 0.31x |
| Financial Leverage | 1.98x | 1.31x |
| Interest Coverage | – | 4086.0x |
| Working Capital | $34M | $83M |
Cash Flow
| Metric | MDWD | NAGE |
|---|---|---|
| Operating Cash Flow | -$39M | $5M |
| Free Cash Flow | -$55M | – |
| Capital Spending | -$16M | – |
| OCF Growth YoY | – | -77.2% |
| FCF/Sales | -114.6% | – |
| CapEx/Sales | 33.0% | – |
Operational Efficiency
| Metric | MDWD | NAGE |
|---|---|---|
| Asset Turnover | 0.56x | 1.13x |
| Receivables Turnover | – | 17.9x |
| Inventory Turnover | 9.8x | 2.1x |
| Fixed Assets Turnover | 2.6x | 100.6x |
| Days Sales Outstanding | – | 20 days |
| Days Inventory | 37 days | 170 days |
| Payables Period | 69 days | 95 days |
| Cash Conversion Cycle | – | 95 days |
Income Statement
| Metric | MDWD | NAGE |
|---|---|---|
| Total Revenue | $48M | $122M |
| Operating Income | -$55M | $5M |
| Net Income | -$74M | $10M |
| R&D Expense | $29M | $6M |
| SG&A Expense | $21M | $41M |
| Cost of Goods Sold | $40M | $44M |
Dividend & Shareholder Information
| Metric | MDWD | NAGE |
|---|---|---|
| Shares Outstanding | 13M | 79M |
| Net Income Growth | – | -49.9% |
| EPS Growth | – | 0.0% |
MDWD vs NAGE: stock comparison and AI forecast
Which is bigger, MDWD or NAGE?
MDWD and NAGE have similar market capitalizations ($171M and $164M).
Which one does Intratio's AI model rank higher, MDWD or NAGE?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.